Nuclei positive to Ezrin | * p value | ||||
---|---|---|---|---|---|
Total | < 50% | 50-89% | > 90% | ||
n | % (n) | % (n) | % (n) | ||
Diagnosis | < 0.001 | ||||
Non-SIL, HPV (−) | 20 | 20 (4) | 50 (10) | 30 (6) | |
Non-SIL, HPV (+) | 24 | 33 (8) | 33 (8) | 33 (8) | |
LSIL | 41 | 29 (12) | 51 (21) | 20 (8) | |
HSIL | 20 | 10 (2) | 30 (6) | 60 (12) | |
Cervical cancer | 20 | 10 (2) | 5 (1) | 85 (17) | |
Viral genotype | |||||
HR-HPV | 45 | 18 (8) | 33 (15) | 49 (22) | 0.001 |
MI HR-HPV | 30 | 13 (4) | 40 (12) | 47 (14) | |
MI HR + LR-HPV | 8 | 0 (0) | 25 (2) | 75 (6) | |
LR-HPV | 20 | 60 (12) | 35 (7) | 5 (1) | |
Negative | 22 | 18 (4) | 45 (10) | 36 (8) | |
HPV Physical status | |||||
Episomal | 5 | 20 (1) | 60 (3) | 20 (1) | 0.115 |
Integrated | 32 | 16 (5) | 19 (6) | 66 (21) | |
Mixed | 41 | 15 (6) | 44 (18) | 41 (17) |